Molecular pharmacology of P2Y-receptors

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 362, Issue 4-5, 2000, Pages 310-323

  Von Kugelgen, I ^a   Wetter, A ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2' DEOXY 6 N METHYLADENOSINE 3',5' BISPHOSPHATE; 2' DEOXY N6 METHYLADENOSINE 3',5' BISPHOSPHONATE; ADENOSINE TRIPHOSPHATE; ADENYLATE CYCLASE; G PROTEIN COUPLED RECEPTOR; ION CHANNEL; MESSENGER RNA; NITRIC OXIDE; NUCLEOTIDE; PHOSPHOLIPASE C; PURINE P2X RECEPTOR; PURINE P2Y RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; PURINERGIC RECEPTOR STIMULATING AGENT; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; RECEPTOR SUBTYPE; SURAMIN; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE; URIDINE TRIPHOSPHATE;

BLOOD VESSEL; BRAIN; CHLORIDE TRANSPORT; DRUG RECEPTOR BINDING; ENZYME ACTIVATION; HEART; HUMAN; LIGAND BINDING; LYMPHOCYTE; NEUROTRANSMISSION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PLACENTA; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTE AGGREGATION;

AMINO ACID SEQUENCE; ANIMALS; HUMANS; MOLECULAR SEQUENCE DATA; RECEPTORS, PURINERGIC P2; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0033756267     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002100000310     Document Type: Review

References (139)

1. Purinoceptors: Are there families of P2X and P2Y purinoceptors?
2. Molecular cloning of a novel P2 purinoceptor from human erythroleukemia cells
3. Proteinase activated receptor 2: Role of extracellular loop 2 for ligand-mediated activation
4. 1 purinoceptor
5. G protein-coupled receptors for ATP and other nucleotides: A new receptor family
6. Nucleotide receptors in the nervous system. An abundant component using diverse transduction mechanisms
7. A novel orphan G protein-coupled receptor primarily expressed in the brain is localized on human chromosomal band 2q21
8. The regulation of vascular function by P2 receptors: Multiple sites and multiple receptors
9. 2 purinoceptors: From molecular biology to functional responses
10. Selective inhibition of M-type potassium channels in rat sympathetic neurons by uridine nucleotide preferring receptors
11. UTP- and ATP-triggered transmitter release from rat sympathetic neurones via separate receptors
12. P2Y receptors: In the middle of the road
13. Early expression of a novel nucleotide receptor in the neural plate of Xenopus embryos
14. 4 nucleotide receptor
15. Differential effects of P2-purinergic receptor antagonists on phospholipase C- and adenylyl cyclase-coupled P(2Y) purinergic receptors
16. 1 receptor
17. Molecular cloning and expression of an avian G protein-coupled P2Y receptor
18. 6-methyl 2'-deoxyadenosine 3',5'-bisphosphate
19. A molecularly identified P2Y receptor simultaneously activates phospholipase C and inhibits adenylyl cyclase and is nonselectively activated by all nucleoside triphosphates
20. The past, present and future of purine nucleotides as signalling molecules
21. 1 receptors
22. A G protein-coupled receptor for UDP-glucose
23. 2 nucleotide receptor
24. PPADS and suramin as antagonists at cloned P(2Y)- and P(2U)-purinoceptors
25. 4 receptors: Characterization of a suramin and PPADS-insensitive response to UTP
26. Molecular cloning and functional characterization of a rat pituitary G protein-coupled adenosine triphosphate (ATP) receptor
27. Binding, gating, affinity and efficacy: The interpretation of structure-activity relationships for agonists and of the effects of mutating receptors
28. Receptors responsive to extracellular pyrimidine nucleotides
29. Cloning and functional expression of a human uridine nucleotide receptor
30. 4 receptor
31. 6 receptor
32. Cloning of a human purinergic P2Y receptor coupled to phospholipase C and adenylyl cyclase
33. 11 receptor
34. ADP is a potent inhibitor of human platelet plasma membrane adenylate cyclase
35. - transport
36. Molecular basis for ADP-induced platelet activation. I. Evidence for three distinct ADP receptors on human platelets
37. Mapping of the P2U purinergic receptor gene to human chromosome 11q 13.5-14.1
38. Functional expression and photoaffinity labeling of a cloned P(2U) purinergic receptor
39. Site-directed mutagenesis of P(2U) purinoceptors. Positively charged amino acids in transmembrane helices 6 and 7 affect agonist potency and specificity
40. Phenotype changes of the vascular smooth muscle cell regulate P2 receptor expression as measured by quantitative RT-PCR
41. 1-deficient mice
42. P2Y1-receptors in human platelets which are pharmacological distinct from P2Y(ADP)-receptors
43. + currents
44. + currents in rat sympathetic neurones
45. 2+ channel in neurones, with both adenosine triphosphates and diphosphates as potent agonists
46. Expression of a cloned P2Y purinergic receptor that couples to phospholipase C
47. Heterogeneity of P2u- and P2y-purinergic receptor regulation of phospholipases in MDCK cells
48. Towards a revised nomenclature for P1 and P2 receptors
49. Suramin analogues as subtype-selective G protein inhibitors
50. The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory
51. Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets
52. 2 nucleotide receptor. Consequences of truncation of the C terminus
53. 1 receptor
54. Characterization by antagonists of P2-receptors mediating endothelium-dependent relaxation in the rat aorta
55. P2-purinergic receptors: Subtype-associated signaling responses and structure
56. Release, metabolism and interconversion of adenine and uridine nucleotides: Implications for G protein-coupled P2 receptor agonist selectivity
57. Actions of extracellular UTP and ATP in perfused rat liver: A comparative study
58. 1-receptor: Similarities to the platelet ADP receptor
59. Uridine nucleotide receptors and their ligands: Structural, physiological, and pathophysiological aspects, with special emphasis on the nervous system
60. Cloning and characterisation of a bovine P2Y receptor
61. 1 receptor in surface expression and activation processes
62. Pharmacological receptors on blood platelets
63. Stimulation by extracellular ATP and UTP of the stress-activated protein kinase cascade in rat mesangial cells
64. Extracellular nucleotides activate the p38-stress-activated protein kinase cascade in glomerular mesangial cells
65. The P(2Y) purinoceptor-operated potassium channel is possibly regulated by the βγ subunits of a pertussis-toxin-insensitive G-protein in cultured rat inferior colliculus neurons
66. P2 purinoceptors and pyrimidinoceptors of catecholamine-producing cells and immunocytes
67. Molecular recognition in P2 receptors: Ligand development aided by molecular modeling and mutagenesis
68. 1 receptor
69. 5 receptor
70. 2 receptor polymorphism: Identification and pharmacological characterization of two allelic variants
71. 1 receptor
72. Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation
73. Metabotropic receptors for ATP and UTP: Exploring the correspondence between native and recombinant nucleotide receptors
74. P2 receptor subtypes in the cardiovascular system
75. Design and pharmacology of selective P2-purinoceptor antagonists
76. PPADS, a novel functionally selective antagonist of P2 purinoceptor-mediated responses
77. Pharmacological selectivity of the cloned human P(2U)-purinoceptor: Potent activation by diadenosine tetraphosphate
78. Cloning and functional characterization of the murine P2Y4 and P2Y6 receptors: Their possible role in gastrointestinal epithelial cell ion transport
79. 1 purinoceptor
80. 1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells
81. 1 receptor-null mice
82. 5 receptor, does not mediate nucleotide-promoted second messenger responses
83. 6 receptor
84. Identification of a receptor/G-protein contact site critical for signaling specificity and G-protein activation
85. Expression cloning of an ATP receptor from mouse neuroblastoma cells
86. Cloning of P2Y6 cDNAs and identification of a pseudogene: Comparison of P2Y receptor subtype expression in bone and brain tissues
87. Novel GPCRs and their endogenous ligands: Expanding the boundaries of physiology and pharmacology
88. Inhibition of platelet adenylate cyclase by ADP
89. The diadenosine polyphosphate receptors: P2D purinoceptors
90. 1 receptor: Molecular modeling and site-directed mutagenesis as tools to identify agonist and antagonist recognition sites
91. 1 receptor
92. P2Y receptor subtypes differentially couple to inwardly-rectifying potassium channels
93. Mitogenic signaling by ATP/P2Y purinergic receptors in astrocytes: Involvement of a calcium-independent protein kinase C, extracellular signal-regulated protein kinase pathway distinct from the phosphatidylinositol-specific pbospbolipase C/calcium pathway
94. Trophic signaling pathways activated by purinergic receptors in rat and human astroglia
95. Cloning, expression, and chromosomal localization of the human uridine nucleotide receptor gene
96. Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: Identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor
97. Coexistence of purino- and pyrimidinoceptors on activated rat microglial cells
98. M-type K(+) currents in rat cultured thoracolumbar sympathetic neurones and their role in uracil nucleotide-evoked noradrenaline release
99. Nucleotide receptors
100. Further subclassification of ATP receptors based on agonist studies
101. 1 receptor expression in Xenopus oocytes
102. 1 receptor
103. Cloning and expression of a human P(2U) nucleotide receptor, a target for cystic fibrosis pharmacotherapy
104. Platelet shape change is mediated by both calcium-dependent and -independent signaling pathways. Role of p160 Rho-associated coiled-coil-containing protein kinase in platelet shape change
105. 6 receptor genes at human chromosome 11q13.3-14.1
106. Receptors for purines and pyrimidines
107. Cloning and expression of the alveolar type II cell P(2α)-purinergic receptor
108. 6 receptor
109. Constriction of the smooth muscle of rat tail and femoral arteries and dog saphenous vein is induced by uridine triphosphate via pyrimidinoceptors, and by adenosine triphosphate via P2x purinoceptors
110. The neighbor-joining method: A new method for reconstructing phylogenetic trees
111. 1 receptor
112. 1-purinoceptor
113. 1 receptor to phospholipase C
114. 35S]ATPαS binding proteins associated with G-proteins
115. Involvement of pyrimidinoceptors in the regulation of cell functions by uridine and by uracil nucleotides
116. 1 cells
117. Functions of extracellular nucleotides in peripheral and central neuronal tissues
118. Characterisation of a recombinant P(2Y) purinoceptor
119. 6 purinoceptor gene and phylogenetic analysis of the P2y purinoceptor family
120. Molecular cloning and sequencing of a novel human P2 nucleotide receptor
121. 2 receptor
122. Cloning of rat and mouse P2Y purinoceptors
123. Modelling the P(2Y) purinoceptor using rhodopsin as template
124. UTP excites rat sympathetic neurons via two independent signalling mechanisms
125. 1 receptor tagged with green-fluorescent protein: High-affinity ligand recognition of adenosine diphosphates and triphosphates and selectivity identical to that of the wild-type receptor
126. Evidence for two separate vasoconstriction-mediating nucleotide receptors, both distinct from the P2x-receptor, in rabbit basilar artery: A receptor for pyrimidine nucleotides and a receptor for purine nucleotides
127. 2 purinoceptor, in rabbit ear artery
128. Differences in the mode of stimulation of cultured rat sympathetic neurons between ATP and UDP
129. 1-receptor
130. Role of action potentials and calcium influx in ATP- and UDP-induced noradrenaline release from rat cultured sympathetic neurones
131. Cloning and functional expression of a brain G-protein-coupled ATP receptor
132. 3) activated preferentially by nucleoside diphosphates
133. Identification of 6H1 as a P2Y purinoceptor: P2Y5
134. 4 receptor
135. 2 receptor subtype from NG108-115 neuroblastoma and glioma hybrid cells
136. Molecular basis of receptor/G-protein-coupling selectivity
137. ATP-stimulated smooth muscle cell proliferation requires independent ERK and PI3K signaling pathways
138. A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis
139. Two novel families of ectonucleotidases: Molecular structures, catalytic properties and a search for function